09:58 AM EST - Avai Bio Inc : Announced that Insulinova has entered into a Research and Option Agreement with Ospedale San Raffaele S.r.l., a leading European biomedical research institution, to collaborate on the development of an encapsulated cell therapy for the treatment of Type 1 and insulin-dependent Type 2 diabetes. Avai Bio Inc
shares O.AVAI are trading up one cent at $0.13.
Full Press Release: https://www.baystreet.ca/quotedata/quote.aspx?ticker=AVAI&qmodStoryID=8549397482391176
